Compare SHEN & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHEN | CTKB |
|---|---|---|
| Founded | 1902 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 673.8M | 541.1M |
| IPO Year | 1994 | 2021 |
| Metric | SHEN | CTKB |
|---|---|---|
| Price | $12.16 | $4.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $26.00 | $5.63 |
| AVG Volume (30 Days) | 340.4K | ★ 745.3K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $357,854,000.00 | $193,015,000.00 |
| Revenue This Year | $7.12 | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 9.08 | ★ 17.67 |
| 52 Week Low | $9.67 | $3.28 |
| 52 Week High | $17.35 | $6.18 |
| Indicator | SHEN | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 51.32 |
| Support Level | $10.94 | $4.17 |
| Resistance Level | $15.82 | $4.70 |
| Average True Range (ATR) | 0.41 | 0.23 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 34.02 | 54.76 |
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.